Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

NCCN Panel Addresses Palliative Care Needs, Emphasizes Team Approach

TON July 2016 Vol 9 No 4 - Palliative Care
Wayne Kuznar

Hollywood, FL—Early intervention utilizing a team approach is important to successful palliative care, agreed a multidisciplinary panel convened at the National Comprehensive Cancer Network (NCCN) 21st Annual Conference.

The multidisciplinary panel offered insight into the value of palliative care in the cancer care continuum, emphasizing the importance of open, continuous dialogue.

The transition from active treatment to palliative care can be challenging, as patients may misperceive palliative care as "giving up," the panel noted, and palliative care planning is difficult to achieve in the typical time allotted to appointments.

The roundtable opened with a personal anecdote by Shirin Malekpour, PhD, Family Member Advocate, University of Wisconsin-Madison, who described her mother's experience with palliative care after being diagnosed with stage III ovarian cancer. "Her medical team was underprepared for our needs in palliative care issues," she said. "We were never offered palliative care or any of the other resources but chemotherapy…here's another surgery, and so forth."

If not for her husband, who worked as a hematologist at the same hospital and knew of the resources available, palliative care would have gone unnoticed. Through this avenue, Dr Malekpour was able to connect with Toby C. Campbell, MD, MSCI, and his team at the University of Wisconsin Carbone Cancer Center, who worked with Dr Malekpour's family to identify her mother's priorities and end-of-life values. (Dr Campbell served as the moderator of the NCCN panel.)

The Practice of Palliative Care

Dr Campbell advised that palliative care be practiced on 3 levels:

    • Primary—the type provided by clinicians who do not often practice palliative care, such as primary care providers
    • Secondary—the routine circumstances in treating seriously ill patients; this type is integral to everyday practice in oncology
    • Tertiary—referral to palliative care services.

Sophia Smith, PhD, MSW, Associate Professor of Nursing at Duke University, Durham, NC, described work at the Duke Cancer Institute around the issue of palliative care. Duke is developing and testing a program called Four Conversations. "It's an educational curriculum around shared decision making," she said. A 2-year study of the program is being funded by NCCN and Pfizer, Inc.

The 4 conversations are between the patient and provider, the patient and his/her loved ones, the patient and spirit, and the patient and him/herself. The program provides online content and offers group-facilitated meetings led by a social worker who is trained in the curriculum. "Patients are able to get together with their peers in a confidential online format," said Dr Smith. The program has evolved from a 1-on-1 format to an online format to make it more accessible and cost-effective. The Four Conversations program was developed specifically for patients with metastatic breast cancer who are receiving end-of-life care, with the purpose of maximizing quality of life and improving relationships with providers, family members, and loved ones. As part of the program, patients are taught mind–body exercises and relaxation training. They are also encouraged to complete advance directives.

"We found that only 15% of our patients who died within the past 2 years had documented directives," she said.

Integrating Palliative Care

A barrier to palliative care planning is a current shortage of palliative care specialists, as clinics are only now building palliative care programs. The traditional model of referral "hasn't worked particularly well," said Dr Campbell, with no-show rates of about 50%, making scheduling difficult. "The next move has been toward integrated, or embedded, palliative care," which places palliative care providers with oncology providers, he said. Home-based palliative care may be the next generation of palliative care, he believes.

"The team approach to [palliative] care is not a substitution, it's an addition" to care already being provided in a clinic, said Maria Dans, MD, Director of Palliative Care Services at the Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis, MO.

Whereas oncologists talk about physical symptoms, palliative care providers tend to talk about emotional and psychological symptoms, issues that may be considered part of advanced care planning, said Dr Campbell. "You can reassure yourselves that your patients won't be spending time going over the same stuff that they've already been over," he said.

Reference

Campbell T. Palliative care: providing comfort from a patient and provider perspective. Presented at: National Comprehensive Cancer Network 21st Annual Conference; March 31-April 2, 2016; Hollywood, FL.

 

Related Items
Pemigatinib Effective in Patients with Cholangiocarcinoma and FGFR2 Fusion or Rearrangement
Wayne Kuznar
TON - February 2020, Vol 13, No 1 published on February 5, 2020 in Cholangiocarcinoma
Practice-Changing Results: Ivosidenib First Targeted Therapy to Show Benefits in Patients with Cholangiocarcinoma and IDH1 Mutation
Wayne Kuznar
TON - February 2020, Vol 13, No 1 published on February 5, 2020 in Cholangiocarcinoma
Noninvasive Molecular Diagnosis Using Circulating DNA Sequencing Improves Outcomes in Cholangiocarcinoma Management
Wayne Kuznar
TON - December 2019, Vol 12, No 6 published on December 5, 2019 in Cholangiocarcinoma
Assessment of Opioid Misuse and Abuse Should Be Part of Cancer Pain Management
Wayne Kuznar
TON - June 2019, Vol 12, No 3 published on June 17, 2019 in Pain Management, NCCN
First Positive Showing for Mesothelin-Directed CAR T-Cell Therapy in Solid Tumors
Wayne Kuznar
TON - June 2019, Vol 12, No 3 published on June 17, 2019 in Immunotherapy
Luspatercept, First-in-Class Erythroid Maturation Agent, Reduces Transfusions in Patients with Low-Risk MDS
Wayne Kuznar
TON - April 2019, Vol 12, No 2 published on April 22, 2019
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Wayne Kuznar
TON - February 2019, Vol 12, No 1 published on March 1, 2019 in Colorectal Cancer
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
TON - February 2019, Vol 12, No 1 published on March 1, 2019 in Leukemia
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
TON - November 2018, Vol 11, No 5 published on November 28, 2018 in Immunotherapy
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
Wayne Kuznar
TON - September 2018, Vol 11, No 4 published on September 19, 2018 in Lynch Syndrome
Last modified: September 9, 2019